Literature DB >> 17094147

The development of hippocampal interneurons in rodents.

Lydia Danglot1, Antoine Triller, Serge Marty.   

Abstract

Interneurons are GABAergic neurons responsible for inhibitory activity in the adult hippocampus, thereby controlling the activity of principal excitatory cells through the activation of postsynaptic GABAA receptors. Subgroups of GABAergic neurons innervate specific parts of excitatory neurons. This specificity indicates that particular interneuron subgroups are able to recognize molecules segregated on the membrane of the pyramidal neuron. Once these specific connections are established, a quantitative regulation of their strength must be performed to achieve the proper balance of excitation and inhibition. We will review when and where interneurons are generated. We will then detail their migration toward and within the hippocampus, and the maturation of their morphological and neurochemical characteristics. We will finally review potential mechanisms underlying the development of GABAergic interneurons. (c) 2006 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2006        PMID: 17094147     DOI: 10.1002/hipo.20225

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  71 in total

1.  Distinct FGFs promote differentiation of excitatory and inhibitory synapses.

Authors:  Akiko Terauchi; Erin M Johnson-Venkatesh; Anna B Toth; Danish Javed; Michael A Sutton; Hisashi Umemori
Journal:  Nature       Date:  2010-05-26       Impact factor: 49.962

2.  Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha.

Authors:  Elizabeth K Lucas; Sean J Markwardt; Swati Gupta; James H Meador-Woodruff; Jiandie D Lin; Linda Overstreet-Wadiche; Rita M Cowell
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.

Authors:  Sharon W Way; Natalia S Rozas; Henry C Wu; James McKenna; R Michelle Reith; S Shahrukh Hashmi; Pramod K Dash; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2012-04-24       Impact factor: 6.150

4.  The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition.

Authors:  Brenda L Bloodgood; Nikhil Sharma; Heidi Adlman Browne; Alissa Z Trepman; Michael E Greenberg
Journal:  Nature       Date:  2013-11-07       Impact factor: 49.962

Review 5.  Orchestrating the synaptic network by tyrosine phosphorylation signalling.

Authors:  Ania Dabrowski; Hisashi Umemori
Journal:  J Biochem       Date:  2011-04-20       Impact factor: 3.387

Review 6.  Specific sets of intrinsic and extrinsic factors drive excitatory and inhibitory circuit formation.

Authors:  Akiko Terauchi; Hisashi Umemori
Journal:  Neuroscientist       Date:  2011-06-07       Impact factor: 7.519

7.  CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.

Authors:  Stephen W Briggs; Wenzhu Mowrey; Charles B Hall; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2013-10-28       Impact factor: 5.864

8.  Early postnatal nicotine exposure disrupts the α2* nicotinic acetylcholine receptor-mediated control of oriens-lacunosum moleculare cells during adolescence in rats.

Authors:  Kang Chen; Sakura Nakauchi; Hailing Su; Saki Tanimoto; Katumi Sumikawa
Journal:  Neuropharmacology       Date:  2015-09-16       Impact factor: 5.250

9.  Impaired function of α2-containing nicotinic acetylcholine receptors on oriens-lacunosum moleculare cells causes hippocampus-dependent memory impairments.

Authors:  Elise Kleeman; Sakura Nakauchi; Hailing Su; Richard Dang; Marcelo A Wood; Katumi Sumikawa
Journal:  Neurobiol Learn Mem       Date:  2016-09-19       Impact factor: 2.877

10.  Synchronous bursts of neuronal activity in the developing hippocampus: modulation by active sleep and association with emerging gamma and theta rhythms.

Authors:  Ethan J Mohns; Mark S Blumberg
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.